Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs Filgrastim for PBPC Mobilization in Lymphoma
NCT00066092Phase 2Completed
- Sponsor
- Amgen
- Start
- Apr 2003
- Primary completion
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Amgen. Started Apr 2003; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00066092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066092.